您的位置: 首页 > 农业专利 > 详情页

COMBINATION THERAPY COMPRISING AN INHIBITOR OF JAK, CDK, AND PIM
专利权人:
发明人:
Zhu Alexander Cao,Maria PINZON-ORTIZ,Xianhui RONG
申请号:
US15710069
公开号:
US20180071296A1
申请日:
2017.09.20
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention relates to a pharmaceutical combination which comprises (a) a JAK inhibitor compound, (b) a CDK inhibitor, and (c) a PIM kinase inhibitor compound, and optionally, at least one pharmaceutically acceptable carrier for simultaneous, separate or sequential use, in particular for the treatment of a myeloid neoplasm or leukemia a pharmaceutical composition comprising such a combination the use of such a combination for the preparation of a medicament for the treatment of myeloid neoplasm or leukemia a commercial package or product comprising such a combination as a combined preparation for simultaneous, separate or sequential use and to a method of treatment of a mammal, especially a human.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充